This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Astrazeneca Ab. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Anne Elizabeth Cooper - Innovator in Pharmaceutical Development
Introduction
Anne Elizabeth Cooper is an inventor based in Loughborough, Leicestershire, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative products aimed at treating respiratory diseases. Although she currently holds no granted patents, her work is noteworthy for its potential impact on healthcare.
Latest Patent Applications
Anne Elizabeth Cooper's latest patent application is titled "PHARMACEUTICAL PRODUCT COMPRISING A P38 KINASE INHIBITOR AND A SECOND ACTIVE INGREDIENT." This invention provides a pharmaceutical product, kit, or composition that includes a first active ingredient, which is N-Cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxo-1(2H)-pyrazinyl]-benzamide or a salt thereof. The second active ingredient can be selected from a variety of compounds, including a non-steroidal Glucocorticoid Receptor (GR Receptor) Agonist, an antioxidant, and several others. This innovative combination aims to enhance treatment options for respiratory diseases.
Conclusion
Anne Elizabeth Cooper is a promising inventor in the pharmaceutical sector, with a focus on developing effective treatments for respiratory conditions. Her latest patent application reflects her commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile